Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Müller

Showing results (441-450 of 651) with videos related to

Pageof 66
Sort By:
Blood Advances|October 18, 2018
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myelomaTilmann Bochtler, Maximilian Merz, Thomas Hielscher, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2009
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiationGünther H S Richter, Stephanie Plehm, Annette Fasan, et al.
Transplantation|February 26, 2019
Greater Susceptibility for Metabolic Syndrome in Pediatric Solid Organ and Stem Cell Transplant RecipientsRicarda Blöte, Nima Memaran, Bianca Borchert-Mörlins, et al.
Molecular Cancer Therapeutics|December 19, 2006
Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptorsEmma Kulimova, Elisabeth Oelmann, Guido Bisping, et al.
Plos One|August 10, 2017
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
Cell Death & Disease|July 28, 2018
MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemiaJens-Uwe Hartmann, Daniela Bräuer-Hartmann, Miroslava Kardosova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasiaBob Löwenberg, Gareth Morgan, Gert J Ossenkoppele, et al.
Plos One|June 13, 2017
Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
International Journal of Oncology|March 16, 2022
Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patientsMaria-Luisa Schubert, Carolina Berger, Alexander Kunz, et al.
Vaccines|February 26, 2022
Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell TransplantationCaroline Pabst, Louise Benning, Nora Liebers, et al.
Pageof 66

Showing results (441-450 of 651) with videos related to

Sort By:
Pageof 66
Blood Advances|October 18, 2018
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myelomaTilmann Bochtler, Maximilian Merz, Thomas Hielscher, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 18, 2009
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiationGünther H S Richter, Stephanie Plehm, Annette Fasan, et al.
Transplantation|February 26, 2019
Greater Susceptibility for Metabolic Syndrome in Pediatric Solid Organ and Stem Cell Transplant RecipientsRicarda Blöte, Nima Memaran, Bianca Borchert-Mörlins, et al.
Molecular Cancer Therapeutics|December 19, 2006
Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptorsEmma Kulimova, Elisabeth Oelmann, Guido Bisping, et al.
Plos One|August 10, 2017
Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
Cell Death & Disease|July 28, 2018
MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemiaJens-Uwe Hartmann, Daniela Bräuer-Hartmann, Miroslava Kardosova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasiaBob Löwenberg, Gareth Morgan, Gert J Ossenkoppele, et al.
Plos One|June 13, 2017
Potential therapeutic impact of CD13 expression in non-small cell lung cancerLars Henning Schmidt, Caroline Brand, Janine Stucke-Ring, et al.
International Journal of Oncology|March 16, 2022
Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patientsMaria-Luisa Schubert, Carolina Berger, Alexander Kunz, et al.
Vaccines|February 26, 2022
Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell TransplantationCaroline Pabst, Louise Benning, Nora Liebers, et al.
Pageof 66